<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The problem of the surveillance for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> after radical surgery is a widely debated argument </plain></SENT>
<SENT sid="1" pm="."><plain>Like for other <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e>, the issue is divided in 2 main routes: the early diagnosis of recurrence and the early diagnosis of a <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">second primary cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Genetic and molecular features have been recognized as useful tools to measure these risks, however, the instruments are still insufficient to design a personalized strategy for the patient </plain></SENT>
<SENT sid="3" pm="."><plain>In an era of "tailored therapies" in <z:hpo ids='HP_0002664'>oncology</z:hpo>, even the follow-up of the surgically treated patient for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> should enter "a tailor's shop in which several competent tailors" should be available to manage a complex problem </plain></SENT>
</text></document>